Pembrolizumab plus chemotherapy versus chemotherapy alone for first-line treatment of advanced oesophageal cancer (KEYNOTE-590): a randomised, placebo-controlled, phase 3 study
Sun, Jong-Mu, Shen, Lin, Shah, Manish A, Enzinger, Peter, Adenis, Antoine, Doi, Toshihiko, Kojima, Takashi, Metges, Jean-Philippe, Li, Zhigang, Kim, Sung-Bae, Cho, Byoung Chul, Mansoor, Wasat, Li, Shau-Hsuan, Sunpaweravong, Patrapim, Maqueda, Maria Alsina, Goekkurt, Eray, Hara, Hiroki, Antunes, Luis, Fountzilas, Christos, Tsuji, Akihito, Oliden, Victor Castro, Liu, Qi, Shah, Sukrut, Bhagia, Pooja, Kato, Ken
Published in The Lancet (British edition) (28.08.2021)
Published in The Lancet (British edition) (28.08.2021)
Get full text
Journal Article
Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial
Özgüroğlu, Mustafa, Mandalà, Mario, Ryu, Min-Hee, Olesiński, Tomasz, Mansoor, Wasat, Shacham-Shmueli, Einat, Chen, Xinqun, Kang, S Peter, Fuchs, Charles S, Lerzo, Guillermo, Lynam, James, Wong, Mark, Vasey, Paul, Van Laethem, Jean-Luc, Van Cutsem, Eric, Berry, Scott, Vincent, Mark, Muller, Bettina, Rey, Felipe, Zambrano, Angela, Guerra, Joaquin, Krogh, Merete, Yilmaz, Mette, Elme, Anneli, Auvinen, Paivi, Alanko, Tuomo, Moehler, Markus, Kunzmann, Volker, Hoehler, Thomas, Haag, Georg, Castro, Hugo, Aguilar Vasquez, Mynor, Cuffe, Sinead, Geva, Ravit, Hubert, Ayala, Beny, Alex, Giuseppe, Aprile, Passalacqua, Rodolfo, Montesarchio, Vincenzo, Chin, Keisho, Nishina, Tomohiro, Komatsu, Yoshito, Hironaka, Shuichi, Satoh, Taroh, Tamura, Takao, Sugimoto, Naotaoshi, Cho, Haruhiko, Omuro, Yashushi, Kato, Ken, Goto, Masahiro, Hyodo, Ichinosuke, Yoshida, Kazuhiro, Baba, Hideo, Esaki, Taito, Furuse, Junji, Wan Mohammed, Wan Zamaniah, Dominguez Andrade, Adriana, Glenjen, Nils, Kubiatowski, Tomasz, Jacek, Jassem, Wojtukiewicz, Marek, Lazarev, Sergey, Lancukhay, Yuri, Moiseyenko, Vladimir, Kostorov, Vladimir, Shirinkin, Vadim, Sakaeva, Dina, Fadeeva, Natalia, Yong, Wei Peng, Robertson, Barbara, Rapaport, Bernardo, Cohen, Graham, Dreosti, Lydia, Szpak, Waldemar, Roh, Sang-Young, Kim, Yeul Hong, Chung, Hyun Cheol, Ryu, Min-Hee, Longo Munoz, Federico, Cervantes Aguilar, Andres, Garcia Alfonso, Pilar, Feliu Batle, Jaime, Yeh, Kun-Huei, Chen, Jen-Shi, Chao, Yee, Kara, Oguz, Hochhauser, Daniel, Chau, Ian, Shaib, Walid, Philip, Philip, Sharma, Vivek, Sun, Weijing, George, Ben, Bullock, Andrea, Myrick, Samuel, Faruol, Josephine, Siegel, Richard, Becerra, Carlos, Richards, Donald A., Riche, Stephen L.
Published in The Lancet (British edition) (14.07.2018)
Published in The Lancet (British edition) (14.07.2018)
Get full text
Journal Article
Health-related quality-of-life analysis from KEYNOTE-590: pembrolizumab plus chemotherapy versus chemotherapy for advanced esophageal cancer
Mansoor, Wasat, Joo, Seongjung, Norquist, Josephine M, Kato, Ken, Sun, Jong-Mu, Shah, Manish A, Enzinger, Peter, Adenis, Antoine, Doi, Toshihiko, Kojima, Takashi, Metges, Jean-Philippe, Li, Zhigang, Kim, Sung-Bae, Cho, Byoung Chol, Sunpaweravong, Patrapim, Alsina Maqueda, Maria, Goekkurt, Eray, Suryawanshi, Shailaja, Shah, Sukrut, Shen, Lin
Published in The oncologist (Dayton, Ohio) (30.05.2024)
Published in The oncologist (Dayton, Ohio) (30.05.2024)
Get full text
Journal Article
Atezolizumab Plus PEGPH20 Versus Chemotherapy in Advanced Pancreatic Ductal Adenocarcinoma and Gastric Cancer: MORPHEUS Phase Ib/II Umbrella Randomized Study Platform
Ko, Andrew H, Kim, Kyu-Pyo, Siveke, Jens T, Lopez, Charles D, Lacy, Jill, O’Reilly, Eileen M, Macarulla, Teresa, Manji, Gulam A, Lee, Jeeyun, Ajani, Jaffer, Alsina Maqueda, Maria, Rha, Sun-Young, Lau, Janet, Al-Sakaff, Nedal, Allen, Simon, Lu, Danny, Shemesh, Colby S, Gan, Xinxin, Cha, Edward, Oh, Do-Youn
Published in The oncologist (Dayton, Ohio) (01.06.2023)
Published in The oncologist (Dayton, Ohio) (01.06.2023)
Get full text
Journal Article
Immunotherapy in gastrointestinal cancer: Recent results, current studies and future perspectives
Moehler, Markus, Delic, Maike, Goepfert, Katrin, Aust, Daniela, Grabsch, Heike I, Halama, Niels, Heinrich, Bernd, Julie, Catherine, Lordick, Florian, Lutz, Manfred P, Mauer, Murielle, Alsina Maqueda, Maria, Schild, Hansjoerg, Schimanski, Carl C, Wagner, Anna-Dorothea, Roth, Arnaud, Ducreux, Michel
Published in European journal of cancer (1990) (01.05.2016)
Published in European journal of cancer (1990) (01.05.2016)
Get full text
Journal Article
Ibrutinib combination therapy for advanced gastrointestinal and genitourinary tumours: results from a phase 1b/2 study
Oh, Do-Youn, Maqueda, Maria Alsina, Quinn, David I, O'Dwyer, Peter J, Chau, Ian, Kim, Sun Young, Duran, Ignacio, Castellano, Daniel, Berlin, Jordan, Mellado, Begona, Williamson, Stephen K, Lee, Keun-Wook, Marti, Francisca, Mathew, Paul, Saif, Muhammad Wasif, Wang, Ding, Chong, Elizabeth, Hilger-Rolfe, Jacqueline, Dean, James P, Arkenau, Hendrik-Tobias
Published in BMC cancer (03.11.2023)
Published in BMC cancer (03.11.2023)
Get full text
Journal Article
First-line pembrolizumab (pembro) plus chemotherapy (chemo) for advanced esophageal cancer: 5-year outcomes from the phase 3 KEYNOTE-590 study
Shah, Manish A., Sun, Jong-Mu, Shen, Lin, Kato, Ken, Enzinger, Peter C., Adenis, Antoine, Doi, Toshihiko, Kojima, Takashi, Li, Zhigang, Kim, Sung-Bae, Cho, Byoung Chul, Mansoor, Wasat, Li, Shau-Hsuan, Sunpaweravong, Patrapim, Alsina Maqueda, Maria, Buchschacher, Gary L, Wu, Jimin, Shah, Sukrut, Bhagia, Pooja, Metges, Jean-Philippe
Published in Journal of clinical oncology (20.01.2024)
Published in Journal of clinical oncology (20.01.2024)
Get full text
Journal Article
Randomized phase 2 study of paclitaxel (PTX), trastuzumab (T) with or without MM-111 in HER2 expressing gastroesophageal cancers (GEC)
Denlinger, Crystal Shereen, Alsina Maqueda, Maria, Watkins, David J., Sym, Sun Jin, Bendell, Johanna C., Park, Se Hoon, Arkenau, Hendrik-Tobias, Bekaii-Saab, Tanios S., Kudla, Art J., McDonagh, Charlotte Fenton, Czibere, Akos Gabor, Chibaudel, Benoist, Press, Michael F., Yoon, Harry H., Hecht, J. Randolph, Cunningham, David, Bang, Yung-Jue
Published in Journal of clinical oncology (20.05.2016)
Published in Journal of clinical oncology (20.05.2016)
Get full text
Journal Article
Phase I study of the PI3K/mTOR inhibitor PF-05212384 in combination with other antitumor agents
Wainberg, Zev A., Shapiro, Geoffrey, Curigliano, Giuseppe, Leong, Stephen, Kristeleit, Rebecca Sophie, Alsina Maqueda, Maria, Britten, Carolyn D., Milella, Michele, Middleton, Mark R., Olszanski, Anthony J., Vaishampayan, Ulka N., Lopez-Martin, Jose A., Gelmon, Karen A., Brega, Nicoletta, Pierce, Kristen J., Perea, Rachelle, Houk, Brett Edward, Pathan, Nuzhat, Gollerkeri, Ashwin, Razak, Albiruni R. A.
Published in Journal of clinical oncology (20.05.2015)
Published in Journal of clinical oncology (20.05.2015)
Get full text
Journal Article
IMAGE, a randomized phase Ib/II study of elisidepsin (E) as a single agent in pretreated advanced gastroesophageal (GE) cancer
Salazar, Ramon, Metges, Jean Philippe, Anthoney, David Alan, Laus, Gianluca, Alsina Maqueda, Maria, Goncalves, Anthony, Montagut, Clara, Brown, Jennifer, Gunzer, Katharina, Szyldergemajn, Sergio A., Petty, Russell D.
Published in Journal of clinical oncology (01.02.2013)
Published in Journal of clinical oncology (01.02.2013)
Get full text
Journal Article